Impact of Fluocinonide 0,05% in Oral Lichen Planus
Status:
Recruiting
Trial end date:
2024-01-03
Target enrollment:
Participant gender:
Summary
A double-blind placebo-controlled trial is conducted in order to evaluate the efficacy of
Fluocinonide 0,05% and determinate the statistical significance of the outcome variables.
Oral cavity lichen is a chronic inflammatory condition affecting the mucosa of the oral
cavity , which significantly reduces the quality of life of affected individuals.